Daily

Evaluation of Tolerability and Safety of “Allergovac Poliplus” in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Conditions:   Allergic Rhinitis;   Rhinoconjunctivitis;   AsthmaIntervention:   Biological: Allergovac PoliplusSponsor:   BIAL Industrial Farmacéutica S.A.Not yet recruiting – verified July 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days